Brain Cancer Canada Invests $75,000 in Groundbreaking Phase 2 Clinical Trial at Sunnybrook Health Sciences Centre to Target Hard-to-Treat Glioblastoma in Older Patients
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.000 · CENTER
Ensemble
0.000 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.054
2,788 articles tracked
7-day bias trend
LcenterR
Article Excerpt
TORONTO, May 14, 2026 (GLOBE NEWSWIRE) — Brain Cancer Canada (BCC), Canada’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide to award $75,000 to a Phase 2 clinical trial led by Dr. Jaime Godoy Santin and colleagues at Sunnybrook Health Sciences Centre in Toronto, Ontario. The study titled “TEMPO trial: Daily...
Read full article at Montreal Gazette ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
pending
May 14, 2026